HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lindsay M Morton Selected Research

Hair Dyes

8/2014Medical history, lifestyle, family history, and occupational risk factors for follicular lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.
8/2014Medical history, lifestyle, family history, and occupational risk factors for diffuse large B-cell lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.
12/2011Hair dye use and risk of bladder cancer in the New England bladder cancer study.
6/2008Personal use of hair dye and the risk of certain subtypes of non-Hodgkin lymphoma.
5/2008Re: Hair dye use, genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma, author response.
8/2007Hair dye use, genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lindsay M Morton Research Topics

Disease

54Neoplasms (Cancer)
05/2022 - 09/2006
25Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2018 - 08/2004
12Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
11/2016 - 05/2008
8Genetic Predisposition to Disease (Genetic Predisposition)
12/2019 - 11/2010
7Breast Neoplasms (Breast Cancer)
10/2021 - 04/2013
7Hodgkin Disease (Hodgkin's Disease)
12/2020 - 05/2010
7Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
10/2014 - 05/2007
7Lymphoma (Lymphomas)
01/2013 - 12/2008
5Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2019 - 11/2010
5Second Primary Neoplasms (Neoplasms, Second)
01/2018 - 11/2010
4Melanoma (Melanoma, Malignant)
01/2022 - 10/2015
4Leukemia
01/2021 - 08/2014
3Thyroid Neoplasms (Thyroid Cancer)
01/2022 - 01/2020
3Sarcoma (Soft Tissue Sarcoma)
11/2020 - 12/2019
3Retinoblastoma (Glioblastoma, Retinal)
11/2020 - 10/2014
3Stomach Neoplasms (Stomach Cancer)
01/2017 - 08/2013
3Infections
11/2016 - 12/2007
3Autoimmune Diseases (Autoimmune Disease)
08/2014 - 08/2014
3Multiple Myeloma
08/2014 - 02/2009
3Obesity
08/2007 - 12/2006
2Ototoxicity
11/2021 - 05/2018
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2021 - 01/2012
2Graft vs Host Disease (Graft-Versus-Host Disease)
09/2020 - 03/2017
2Ewing Sarcoma (Sarcoma, Ewing)
01/2020 - 09/2015
2GATA2 Deficiency
12/2019 - 03/2017
2Inflammation (Inflammations)
05/2018 - 07/2009
2Lung Neoplasms (Lung Cancer)
11/2017 - 04/2013
2Lymphoproliferative Disorders (Lymphoproliferative Disorder)
03/2017 - 12/2007
2Prostatic Neoplasms (Prostate Cancer)
10/2016 - 08/2013
2T-Cell Lymphoma (Lymphoma, T Cell)
01/2016 - 05/2010
2Urinary Bladder Neoplasms (Bladder Cancer)
12/2015 - 12/2011
2Esophageal Neoplasms (Esophageal Cancer)
10/2014 - 07/2013
2Seasonal Allergic Rhinitis (Hay Fever)
08/2014 - 08/2014
2Eczema
08/2014 - 08/2014
2Plasma Cell Neoplasms
05/2010 - 06/2009
1Hypopituitarism (Sheehan's Syndrome)
01/2022
1Diarrhea
01/2022
1Cushing Syndrome
01/2022
1Hypothyroidism
01/2022
1Hyperthyroidism
01/2022
1Sepsis (Septicemia)
01/2022
1Dizziness (Lightheadedness)
11/2021
1Vertigo (Positional Vertigo)
11/2021
1Hearing Loss (Hearing Impairment)
11/2021
1Tinnitus
11/2021
1Hypertension (High Blood Pressure)
03/2021
1Genetic Risk Score
03/2021
1Papillary Thyroid Cancer
01/2021
1Leiomyosarcoma
11/2020
1Central Nervous System Neoplasms
11/2020
1Carcinoma (Carcinomatosis)
09/2020
1Meningioma (Meningiomas)
01/2020
1Osteosarcoma (Osteogenic Sarcoma)
01/2020
1Basal Cell Carcinoma (Rodent Ulcer)
01/2020

Drug/Important Bio-Agent (IBA)

6Hair DyesIBA
08/2014 - 08/2007
5DNA (Deoxyribonucleic Acid)IBA
01/2021 - 06/2012
5HLA Antigens (Human Leukocyte Antigens)IBA
01/2018 - 06/2010
5Rituximab (Mabthera)FDA Link
10/2015 - 10/2008
5N-acetyltransferase 1IBA
01/2013 - 08/2006
4Alkylating AgentsIBA
12/2019 - 11/2010
4ORALIT (ORS)IBA
12/2019 - 05/2008
3Topoisomerase II InhibitorsIBA
01/2021 - 01/2019
3Proteins (Proteins, Gene)FDA Link
01/2020 - 01/2009
3Biological ProductsIBA
10/2018 - 01/2012
3CytokinesIBA
01/2017 - 01/2009
3AcetyltransferasesIBA
01/2013 - 08/2006
3EnzymesIBA
01/2013 - 08/2006
3AminesIBA
06/2012 - 08/2006
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2011 - 12/2008
2IodineIBA
01/2022 - 01/2021
2Hormones (Hormone)IBA
10/2021 - 06/2009
2Dacarbazine (DIC)FDA LinkGeneric
12/2020 - 09/2013
2fludarabineIBA
09/2020 - 10/2015
2AnthracyclinesIBA
12/2019 - 01/2018
2Estrogen ReceptorsIBA
12/2019 - 03/2018
2Pharmaceutical PreparationsIBA
05/2018 - 06/2014
2Biomarkers (Surrogate Marker)IBA
01/2017 - 01/2016
2HLA-A Antigens (HLA-A)IBA
11/2016 - 01/2011
2insulin receptor-related receptor (IRR)IBA
11/2016 - 01/2012
2Transcription Factors (Transcription Factor)IBA
09/2015 - 01/2009
2HLA-DRB1 Chains (HLA DRB1)IBA
01/2011 - 06/2010
2CaspasesIBA
12/2009 - 07/2009
1Immune Checkpoint InhibitorsIBA
01/2022
1Antidepressive Agents (Antidepressants)IBA
11/2021
1Bleomycin (Blenoxane)FDA LinkGeneric
12/2020
1Doxorubicin (Adriamycin)FDA LinkGeneric
12/2020
1Vinblastine (Vinblastine Sulfate)FDA Link
12/2020
1PlatinumIBA
11/2020
1Melphalan (Alkeran)FDA LinkGeneric
09/2020
1Busulfan (Busulfex)FDA Link
09/2020
1Oncogene Proteins (Oncogene Protein)IBA
01/2020

Therapy/Procedure

31Radiotherapy
11/2021 - 04/2013
17Therapeutics
05/2022 - 12/2006
15Drug Therapy (Chemotherapy)
01/2021 - 11/2010
8Transplantation
03/2017 - 12/2007
4Organ Transplantation
11/2016 - 12/2007
4Blood Transfusion (Blood Transfusions)
08/2014 - 08/2004
2Cell Transplantation
09/2020 - 03/2017
2Highly Active Antiretroviral Therapy (HAART)
09/2014 - 03/2014
1Nuclear Power Plants
01/2021